LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference
Rhea-AI Summary
LifeMD (NASDAQ:LFMD), a virtual primary care services provider, announced its participation in the upcoming Canaccord Genuity 45th Annual Growth Conference. The event will take place at the InterContinental Boston from August 12-14, 2025.
Company management will engage in a fireside chat on August 13th at 8:30 AM ET and conduct one-on-one investor meetings during August 12-13. Interested investors can register through their Canaccord Genuity representative.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, LFMD gained 24.25%, reflecting a significant positive market reaction. Argus tracked a peak move of +28.7% during that session. Argus tracked a trough of -23.7% from its starting point during tracking. Our momentum scanner triggered 90 alerts that day, indicating high trading interest and price volatility. This price movement added approximately $111M to the company's valuation, bringing the market cap to $568M at that time. Trading volume was very high at 3.8x the daily average, suggesting strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the Canaccord Genuity 45th Annual Growth Conference, which will be held August 12-14, 2025 at the InterContinental Boston. Management will participate in a fireside chat on Wednesday, August 13th at 8:30 a.m. Eastern time and will hold one-on-one meetings with investors on August 12-13.
Investors can register for the conference by contacting their Canaccord Genuity representative.
About LifeMD, Inc.
LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com